Literature DB >> 24672048

Enterovirus 68 3C protease cleaves TRIF to attenuate antiviral responses mediated by Toll-like receptor 3.

Zichun Xiang1, Linlin Li1, Xiaobo Lei1, Hongli Zhou1, Zhuo Zhou1, Bin He2, Jianwei Wang3.   

Abstract

UNLABELLED: Human enterovirus 68 (EV68) is a member of the EV-D species, which belongs to the EV genus of the Picornaviridae family. Over the past several years, there have been increasingly documented outbreaks of respiratory disease associated with EV68. As a globally emerging pathogen, EV68 infects both adults and children. However, the molecular basis of EV68 pathogenesis is unknown. Here we report that EV68 inhibits Toll-like receptor 3 (TLR3)-mediated innate immune responses by targeting the TIR domain-containing adaptor inducing beta interferon (TRIF). In infected HeLa cells, EV68 inhibits poly(I·C)-induced interferon regulatory factor 3 (IRF3) activation and beta interferon (IFN-β) expression. Further investigations revealed that TRIF, a critical adaptor downstream of TLR3, is targeted by EV68. When expressed alone, 3C(pro), an EV68-encoded protease, cleaves TRIF. 3C(pro) mediates TRIF cleavage at Q312 and Q653, which are sites in the amino- and carboxyl-terminal domains, respectively. This cleavage relies on 3C(pro)'s cysteine protease activity. Cleavage of TRIF abolishes the capacity of TRIF to activate NF-κB and IFN-β signaling. These results suggest that control of TRIF by 3C(pro) may be a mechanism by which EV68 subverts host innate immune responses. IMPORTANCE: EV68 is a globally emerging pathogen, but the molecular basis of EV68 pathogenesis is unclear. Here we report that EV68 inhibits TLR3-mediated innate immune responses by targeting TRIF. Further investigations revealed that TRIF is cleaved by 3C(pro). These results suggest that control of TRIF by 3C(pro) may be a mechanism by which EV68 impairs type I IFN production in response to TLR3 activation.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24672048      PMCID: PMC4054379          DOI: 10.1128/JVI.03138-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.

Authors:  Zongdi Feng; Melissa Cerveny; Zhipeng Yan; Bin He
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

3.  TRIF is a critical survival factor in viral cardiomyopathy.

Authors:  Alexander Riad; Dirk Westermann; Christin Zietsch; Konstantinos Savvatis; Peter M Becher; Stefan Bereswill; Markus M Heimesaat; Olga Lettau; Dirk Lassner; Andrea Dörner; Wolfgang Poller; Matthias Busch; Stephan B Felix; Heinz P Schultheiss; Carsten Tschöpe
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

4.  The 3C protein of enterovirus 71 inhibits retinoid acid-inducible gene I-mediated interferon regulatory factor 3 activation and type I interferon responses.

Authors:  Xiaobo Lei; Xinlei Liu; Yijie Ma; Zhenmin Sun; Yaowu Yang; Qi Jin; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

5.  Worldwide emergence of multiple clades of enterovirus 68.

Authors:  Rafal Tokarz; Cadhla Firth; Shabir A Madhi; Stephen R C Howie; Winfred Wu; Amadou Alpha Sall; Saddef Haq; Thomas Briese; W Ian Lipkin
Journal:  J Gen Virol       Date:  2012-06-13       Impact factor: 3.891

Review 6.  Selective inhibitors of picornavirus replication.

Authors:  Armando M De Palma; Inge Vliegen; Erik De Clercq; Johan Neyts
Journal:  Med Res Rev       Date:  2008-11       Impact factor: 12.944

7.  RIG-I is cleaved during picornavirus infection.

Authors:  Paola M Barral; Devanand Sarkar; Paul B Fisher; Vincent R Racaniello
Journal:  Virology       Date:  2009-07-22       Impact factor: 3.616

8.  Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses.

Authors:  M Steven Oberste; Kaija Maher; David Schnurr; Mary R Flemister; Judith C Lovchik; Heather Peters; Wendy Sessions; Carol Kirk; Nando Chatterjee; Susan Fuller; J Michael Hanauer; Mark A Pallansch
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

9.  Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses.

Authors:  Xiaobo Lei; Xia Xiao; Qinghua Xue; Qi Jin; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

10.  Lineages, sub-lineages and variants of enterovirus 68 in recent outbreaks.

Authors:  Ina L Lauinger; Jon M Bible; Eugene P Halligan; Emma J Aarons; Eithne MacMahon; Cheuk Y W Tong
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

View more
  38 in total

1.  Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice.

Authors:  Brett L Hurst; W Joseph Evans; Donald F Smee; Arnaud J Van Wettere; E Bart Tarbet
Journal:  Virology       Date:  2018-10-31       Impact factor: 3.616

2.  Enterovirus 3A Facilitates Viral Replication by Promoting Phosphatidylinositol 4-Kinase IIIβ-ACBD3 Interaction.

Authors:  Xia Xiao; Xiaobo Lei; Zhenzhen Zhang; Yijie Ma; Jianli Qi; Chao Wu; Yan Xiao; Li Li; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

3.  Disruption of MDA5-Mediated Innate Immune Responses by the 3C Proteins of Coxsackievirus A16, Coxsackievirus A6, and Enterovirus D68.

Authors:  Yajuan Rui; Jiaming Su; Hong Wang; Junliang Chang; Shaohua Wang; Wenwen Zheng; Yong Cai; Wei Wei; James T Gordy; Richard Markham; Wei Kong; Wenyan Zhang; Xiao-Fang Yu
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

Review 4.  Activation and pathogenic manipulation of the sensors of the innate immune system.

Authors:  Charlotte Odendall; Jonathan C Kagan
Journal:  Microbes Infect       Date:  2017-01-14       Impact factor: 2.700

5.  HSV-1\EGFP stimulates miR-146a expression in a NF-κB-dependent manner in monocytic THP-1 cells.

Authors:  Assunta Venuti; Maria Musarra-Pizzo; Rosamaria Pennisi; Stoyan Tankov; Maria Antonietta Medici; Antonio Mastino; Ana Rebane; Maria Teresa Sciortino
Journal:  Sci Rep       Date:  2019-03-26       Impact factor: 4.379

6.  Enterovirus 3C Protease Cleaves TRIM7 To Dampen Its Antiviral Activity.

Authors:  Wenchun Fan; Matthew B McDougal; John W Schoggins
Journal:  J Virol       Date:  2022-09-15       Impact factor: 6.549

Review 7.  Recent advances on viral manipulation of NF-κB signaling pathway.

Authors:  Jun Zhao; Shanping He; Arlet Minassian; Junhua Li; Pinghui Feng
Journal:  Curr Opin Virol       Date:  2015-09-15       Impact factor: 7.090

8.  3C Protease of Enterovirus D68 Inhibits Cellular Defense Mediated by Interferon Regulatory Factor 7.

Authors:  Zichun Xiang; Lulu Liu; Xiaobo Lei; Zhuo Zhou; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

Review 9.  Interference with nuclear factor kappaB signaling pathway by pathogen-encoded proteases: global and selective inhibition.

Authors:  Andrea Hodgson; Fengyi Wan
Journal:  Mol Microbiol       Date:  2015-11-05       Impact factor: 3.501

10.  Enterovirus D68 Protease 2Apro Targets TRAF3 To Subvert Host Innate Immune Responses.

Authors:  Jun Kang; Zheng Pang; Zhenwei Zhou; Xianhuang Li; Sihua Liu; Jinyan Cheng; Peiyuan Liu; Wenjie Tan; Zhiyun Wang; Tao Wang
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.